Francesco Pasqualetti

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Giuseppe Lombardi, Gian Luca De Salvo, Alba A. Brandes et al. · The Lancet Oncology · 2018 · 386 citations

Medicine, Oncology, Pharmacology +13

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study

Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini et al. · World Journal of Urology · 2019 · 98 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO

Silvia Scoccianti, Emanuela Olmetto, Valentina Pinzi et al. · Neuro-Oncology · 2021 · 90 citations · Full text

Medicine, Oncology, Radiation Oncology +17

[18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results

Francesco Pasqualetti, M. Panichi, A. Sainato et al. · Radiation Oncology · 2016 · 86 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)

Riccardo Soffietti, Elisa Trevisan, Luca Bertero et al. · Journal of Neuro-Oncology · 2013 · 72 citations · Full text

Medicine, Oncology, Pharmacotherapy +17